Data on mRNA vaccines sent by Moderna to European regulators before the COVID-19 outbreak included early tests of the mRNA ...

MRNA's competitive landscape, particularly against Pfizer, and higher forward P/S ratio suggest the stock is overvalued and ...

A member of the U.K. Parliament is calling for regulators to audit pharmaceutical companies that have made misleading ...

Shares of vaccine companies such as Moderna (MRNA), Pfizer (PFE) and BioNTech (BNTX), among others, are falling after a ...

A number of High Street chemists and private clinics sell and administer the Pfizer Covid vaccine directly to the public. The ...

Drugmaker Pfizer posted a better-than-expected fourth-quarter profit on Thursday, helped by cost cuts it began last year as ...

Pfizer’s RSV vaccine has struggled to compete with one from GSK in a market that now also includes Moderna. Bloomberg Intelligence analyst John Murphy called the earnings report “largely ...

Vaccines are designed to guard babies, toddlers, and older children against a whole range of serious and potentially deadly ...

Pfizer and Merck, ostensibly beleaguered drugmakers, have seen their shares battered despite reporting strong earnings.

Pfizer’s contributions to animal health date back several decades, during which the company played a significant role in ...

Moderna's stock fell more ... of Novavax and GSK both fell around 1%. Pfizer's stock fell almost 2%, even after the company ...

Pfizer makes the Comirnaty vaccine with German partner BioNTech ... is likely benefiting from brand loyalty versus competitor Moderna. Sales of its heart disease drug, sold as Vyndaqel and ...